Pay in 4 interest-free payments of $6.01 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
Another 5% to 10% were low responders, losing less than 10% despite completing the full protocol
In the Step 1 trial (note: funded by Novo-Nordisk) of 1,961 individuals, the average weight loss at 68 weeks was 14.9% at the maximum dose of 2.4 mg weekly, equating to 15.3 kg (33.6 lbs) lost compared to 2.6 kg (5.7 lbs) in the placebo group
When patients ask about tirzepatide oral tablet options, they are usually referring to compounded tirzepatide tablets
Yoshiji S, Murakami T, Harashima SI, et al
By engaging both of these pathways, tirzepatide can: Enhance insulin secretion Reduce appetite Slow gastric emptying Improve glycemic (blood sugar) control Clinical research has demonstrated that tirzepatide can result in greater weight loss and improved metabolic health compared to traditional GLP-1 agonists
US$ 28.58
US$ 27.24
US$ 26.93
US$ 28.08
